Introduction : Pulmonary rehabilitation has demonstrated significant improvements among COPD pati... more Introduction : Pulmonary rehabilitation has demonstrated significant improvements among COPD patients. The effect on non COPD patients is less well established. Aims and Objective: We wanted to find out whether pulmonary rehabilitation is also beneficial in non COPD patients. Methods: We collected the data about one hundred and three non COPD patients that participated in pulmonary rehabilitation program in our hospital . The program took place in hospital environment and was run according to the ERS/ATS guidelines on pulmonary rehabilitation. Six minute walk (6MW) test was performed at the beginning of the program and at the end. Saint George Respiratory Questioner (SGRQ) was also performed at the beginning and at the end. Result: We included One hundred and three non COPD patients participated in the program between 2009 to 2013. Seventy three patients with interstitial lung disease (ILD), 23 with Asthma and seven with pulmonary hypertension. All the patients demonstrated significant impressive improvement in 6MW test and in SGRQ. The patients suffering from ILD demonstrated fifty four meters (18.2%) improvement in the 6MW test (P Conclusions: We conclude that pulmonary rehabilitation is effective in interstitial lung disease, asthma and pulmonary hypertension. We believe that pulmonary rehabilitation should be offered to the majority of patients suffering from chronic respiratory disease.
Introduction: Pulmonary rehabilitation is regarded as a crucial component of the therapeutic arma... more Introduction: Pulmonary rehabilitation is regarded as a crucial component of the therapeutic armamentarium in chronic lung disease. Ten years ago the Pulmonary Rehabilitation Service at the Shaare Zedek Medical Center (SZMC) was established as part of the Cardiac Rehabilitation Center. Over the last six years this service operates independently within the physiotherapy center under the supervision of the Pulmonary Institute, in collaboration with the social and nutritional services. Aims: To evaluate the efficacy of pulmonary rehabilitation in improving the patients' quality of life and functional capacity. Methods: Prospective follow-up of patients referred for pulmonary rehabilitation at the SZMC between the years 2009-2013. The participants were required to complete a pulmonary function test, a 6 minute walk test (6MWT) and a quality of life questionnaire, the Saint George Respiratory Questionnaire (SGRQ). The SGRQ and the 6MWT were readministered after completion of the program. Results: During the follow-up period 415 patients underwent pulmonary rehabilitation at SZMC, of them 330 completed a series of at least 12 sessions. Complete data pertaining to the 6MWTwas obtained for 276 subjects. Participation in the program led to an improvement of 57.5 meters (p < 0.001) in the walking distance. Complete data regarding the SGRQ were available for 94 patients. Completion of the pulmonary rehabilitation program led to a decrease of 8.9 points in the SGRQ (p < 0.001). Conclusions: Our results indicate that pulmonary rehabilitation was clinically useful as well as statistically significant in improving the functional capacity and quality of life among patients with chronic lung diseases.
BACKGROUND Pulmonary rehabilitation has shown significant benefit for patients with chronic obstr... more BACKGROUND Pulmonary rehabilitation has shown significant benefit for patients with chronic obstructive pulmonary disease (COPD). The effect on non-COPD pulmonary patients is less well established. OBJECTIVES To determine whether pulmonary rehabilitation is also beneficial for non-COPD pulmonary patients. METHODS Clinical and demographic data on non-COPD pulmonary patients who participated in our institutional pulmonary rehabilitation program between January 2009 and December 2016 were collected. Participants engaged in a 60-minute, twice-weekly, ambulatory hospital-based program lasting 12 to 24 sessions. Sessions included both endurance and muscle training as well as healthy lifestyle educational activities. The six-minute walk test (6MWT) and the St. George's Respiratory Questionnaire (SGRQ) were conducted before and after the rehabilitation program. RESULTS We recruited 214 non-COPD patients, of whom 153 completed at least 12 sessions. Of these, 59 presented with interstitial lung disease (ILD), 18 with non-ILD restrictive lung defects, 25 with asthma, 30 with lung cancer, and 21 with other conditions (e.g., pulmonary hypertension, bronchiectasis) The groups demonstrated significant improvement in 6MWT and in SGRQ scores. Non-COPD patients gained a 61.9 meter (19%) improvement in the 6MWT (P < 0.0001) and 8.3 point reduction in their SGRQ score (P < 0.0001). CONCLUSIONS Pulmonary rehabilitation is effective in non-COPD pulmonary patients. As such, it should be an integral part of the treatment armament provided to the vast majority of those suffering from chronic respiratory disease.
Poster: "ECR 2019 / C-3047 / The utility of dual energy CT in diagnosis of amiodarone induce... more Poster: "ECR 2019 / C-3047 / The utility of dual energy CT in diagnosis of amiodarone induced lung disease: a prospective cohort study" by: "N. R. Bogot, I. Hadas-Halpern, J. Cohen, A. Rokach, G. Izbicki, O. Benjaminov, N. Arish; Jerusalem/IL"
COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort... more COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort study of patients with COVID-19, we sought to characterize the prevalence and persistence of symptoms up to 18 months after diagnosis. We followed 166 patients and assessed their symptoms during acute illness, and at 3 and 18 months after disease onset. The mean number of symptoms per patient during acute disease was 2.3 (SD:1.2), dropping to 1.8 (SD:1.1) at 3 months after recovery and to 0.6 (SD:0.9) at 18 months after recovery. However, this decrease was not unidirectional. Between acute illness and 3 months, the frequency of symptoms decreased for cough (64.5%→24.7%), ageusia (21.7% to6%), anosmia (17.5%→5.4%), and generalized pain (10.8% to 5.4%) but increased for dyspnea (53%→57.2%) weakness (47%→54.8%), and brain fog (3%→8.4%). Between 3 and 18 months, the frequency of symptoms decreased for all symptoms but remained relatively high for dyspnea (15.8%), weakness (21.2%), and brain...
Introduction : Pulmonary rehabilitation has demonstrated significant improvements among COPD pati... more Introduction : Pulmonary rehabilitation has demonstrated significant improvements among COPD patients. The effect on non COPD patients is less well established. Aims and Objective: We wanted to find out whether pulmonary rehabilitation is also beneficial in non COPD patients. Methods: We collected the data about one hundred and three non COPD patients that participated in pulmonary rehabilitation program in our hospital . The program took place in hospital environment and was run according to the ERS/ATS guidelines on pulmonary rehabilitation. Six minute walk (6MW) test was performed at the beginning of the program and at the end. Saint George Respiratory Questioner (SGRQ) was also performed at the beginning and at the end. Result: We included One hundred and three non COPD patients participated in the program between 2009 to 2013. Seventy three patients with interstitial lung disease (ILD), 23 with Asthma and seven with pulmonary hypertension. All the patients demonstrated significant impressive improvement in 6MW test and in SGRQ. The patients suffering from ILD demonstrated fifty four meters (18.2%) improvement in the 6MW test (P Conclusions: We conclude that pulmonary rehabilitation is effective in interstitial lung disease, asthma and pulmonary hypertension. We believe that pulmonary rehabilitation should be offered to the majority of patients suffering from chronic respiratory disease.
Introduction: Pulmonary rehabilitation is regarded as a crucial component of the therapeutic arma... more Introduction: Pulmonary rehabilitation is regarded as a crucial component of the therapeutic armamentarium in chronic lung disease. Ten years ago the Pulmonary Rehabilitation Service at the Shaare Zedek Medical Center (SZMC) was established as part of the Cardiac Rehabilitation Center. Over the last six years this service operates independently within the physiotherapy center under the supervision of the Pulmonary Institute, in collaboration with the social and nutritional services. Aims: To evaluate the efficacy of pulmonary rehabilitation in improving the patients' quality of life and functional capacity. Methods: Prospective follow-up of patients referred for pulmonary rehabilitation at the SZMC between the years 2009-2013. The participants were required to complete a pulmonary function test, a 6 minute walk test (6MWT) and a quality of life questionnaire, the Saint George Respiratory Questionnaire (SGRQ). The SGRQ and the 6MWT were readministered after completion of the program. Results: During the follow-up period 415 patients underwent pulmonary rehabilitation at SZMC, of them 330 completed a series of at least 12 sessions. Complete data pertaining to the 6MWTwas obtained for 276 subjects. Participation in the program led to an improvement of 57.5 meters (p < 0.001) in the walking distance. Complete data regarding the SGRQ were available for 94 patients. Completion of the pulmonary rehabilitation program led to a decrease of 8.9 points in the SGRQ (p < 0.001). Conclusions: Our results indicate that pulmonary rehabilitation was clinically useful as well as statistically significant in improving the functional capacity and quality of life among patients with chronic lung diseases.
BACKGROUND Pulmonary rehabilitation has shown significant benefit for patients with chronic obstr... more BACKGROUND Pulmonary rehabilitation has shown significant benefit for patients with chronic obstructive pulmonary disease (COPD). The effect on non-COPD pulmonary patients is less well established. OBJECTIVES To determine whether pulmonary rehabilitation is also beneficial for non-COPD pulmonary patients. METHODS Clinical and demographic data on non-COPD pulmonary patients who participated in our institutional pulmonary rehabilitation program between January 2009 and December 2016 were collected. Participants engaged in a 60-minute, twice-weekly, ambulatory hospital-based program lasting 12 to 24 sessions. Sessions included both endurance and muscle training as well as healthy lifestyle educational activities. The six-minute walk test (6MWT) and the St. George's Respiratory Questionnaire (SGRQ) were conducted before and after the rehabilitation program. RESULTS We recruited 214 non-COPD patients, of whom 153 completed at least 12 sessions. Of these, 59 presented with interstitial lung disease (ILD), 18 with non-ILD restrictive lung defects, 25 with asthma, 30 with lung cancer, and 21 with other conditions (e.g., pulmonary hypertension, bronchiectasis) The groups demonstrated significant improvement in 6MWT and in SGRQ scores. Non-COPD patients gained a 61.9 meter (19%) improvement in the 6MWT (P < 0.0001) and 8.3 point reduction in their SGRQ score (P < 0.0001). CONCLUSIONS Pulmonary rehabilitation is effective in non-COPD pulmonary patients. As such, it should be an integral part of the treatment armament provided to the vast majority of those suffering from chronic respiratory disease.
Poster: "ECR 2019 / C-3047 / The utility of dual energy CT in diagnosis of amiodarone induce... more Poster: "ECR 2019 / C-3047 / The utility of dual energy CT in diagnosis of amiodarone induced lung disease: a prospective cohort study" by: "N. R. Bogot, I. Hadas-Halpern, J. Cohen, A. Rokach, G. Izbicki, O. Benjaminov, N. Arish; Jerusalem/IL"
COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort... more COVID-19 is characterized by persistent symptoms beyond acute illness. In this prospective cohort study of patients with COVID-19, we sought to characterize the prevalence and persistence of symptoms up to 18 months after diagnosis. We followed 166 patients and assessed their symptoms during acute illness, and at 3 and 18 months after disease onset. The mean number of symptoms per patient during acute disease was 2.3 (SD:1.2), dropping to 1.8 (SD:1.1) at 3 months after recovery and to 0.6 (SD:0.9) at 18 months after recovery. However, this decrease was not unidirectional. Between acute illness and 3 months, the frequency of symptoms decreased for cough (64.5%→24.7%), ageusia (21.7% to6%), anosmia (17.5%→5.4%), and generalized pain (10.8% to 5.4%) but increased for dyspnea (53%→57.2%) weakness (47%→54.8%), and brain fog (3%→8.4%). Between 3 and 18 months, the frequency of symptoms decreased for all symptoms but remained relatively high for dyspnea (15.8%), weakness (21.2%), and brain...
Uploads
Papers by Ariel Rokach